We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Supratherapeutic International Normalized Ratios in Warfarin-Treated Patients Who Receive a Highly Potentiating Antimicrobial Course

Lisa M. Daniels, MD1; Jason N. Barreto, PharmD2; Pritish K. Tosh, MD3
[+] Author Affiliations
1Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota
2Department of Pharmacy Services, Mayo Clinic, Rochester, Minnesota
3Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota
JAMA Intern Med. 2014;174(7):1200. doi:10.1001/jamainternmed.2014.1615.
Text Size: A A A
Published online


To the Editor We read with great interest the recent article by Clark et al.1 The use of sick controls was innovative and valuable to future studies evaluating international normalized ratio (INR) fluctuations in patients receiving long-term warfarin therapy. The authors did not identify a significantly increased proportion of patients with an INR above 5.0 among those receiving antimicrobials compared with sick controls. However, an analysis of their published data suggests that the difference observed between those receiving antimicrobials who inhibit cytochrome P450 metabolism, particularly the 2C9 enzyme (ie, metronidazole and trimethoprim-sulfamethoxazole) and sick controls was significant (8.6% vs 2.6%; P < .001), suggesting that although antimicrobials as a whole do not cause elevations in INR compared with sick controls, a select subset of highly potentiating antimicrobials will demonstrate a significant effect. We would be interested to know if the authors were able to perform this subgroup analysis and if other highly potentiating antimicrobials (eg, fluconazole, miconazole, voriconazole) were captured for analysis. Other studies have suggested that highly potentiating antimicrobials have a significant impact on INR.25 If it appears that these highly potentiating antimicrobials contribute to a substantially increased INR in patients taking warfarin for chronic anticoagulation, then interventions in the ambulatory care setting are needed to reduce this risk in these patients.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





July 1, 2014
Catherine S. Riggs, PharmD; Thomas Delate, PhD; Nathan P. Clark, PharmD
1Department of Clinical Pharmacy, Kaiser Permanente, Aurora, Colorado
1Department of Clinical Pharmacy, Kaiser Permanente, Aurora, Colorado2Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Denver
JAMA Intern Med. 2014;174(7):1200-1201. doi:10.1001/jamainternmed.2014.1589.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...